Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

LMP1 structure and signal transduction.

A G Eliopoulos1, L S Young

  • 1CRC Institute for Cancer Studies, The University of Birmingham Medical School, Birmingham, B15 2TA, UK. A.G.Eliopoulos@bham.ac.uk

Seminars in Cancer Biology
|October 24, 2001
PubMed
Summary

The Epstein-Barr virus (EBV) protein LMP1 acts like an active receptor, triggering cell signaling pathways. This explains how EBV contributes to cell transformation and cancer development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Apolipoprotein A-I inhibits experimental colitis and colitis-propelled carcinogenesis.

Oncogene·2015
Same author

Physical and functional interaction of the TPL2 kinase with nucleophosmin.

Oncogene·2014
Same author

Adenovirus delivery of human CD40 ligand gene confers direct therapeutic effects on carcinomas.

Cancer gene therapy·2009
Same author

Activated T-lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia.

British journal of haematology·2005
Same author

Expression of SRC-1, AIB1, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1.

Journal of clinical pathology·2004
Same author

CD40 expression in prostate cancer: a potential diagnostic and therapeutic molecule.

Oncology reports·2004

Area of Science:

  • Virology
  • Molecular Biology
  • Cancer Research

Background:

  • Epstein-Barr virus (EBV) is an oncogenic virus.
  • Latent membrane protein 1 (LMP1) is a key EBV-encoded protein.
  • LMP1 shares features with constitutively active TNF family receptors.

Purpose of the Study:

  • To elucidate the molecular mechanisms behind LMP1's transforming properties.
  • To explain how LMP1 activates cellular signaling pathways.

Main Methods:

  • Analysis of LMP1's structural and functional characteristics.
  • Investigating LMP1's aggregation at the plasma membrane.
  • Identifying downstream signaling pathways activated by LMP1.

Main Results:

  • LMP1 aggregates at the plasma membrane.
  • LMP1 activates multiple signaling cascades, including NF-κB, JNK, p38, Cdc42, and JAK/STAT.
  • These signaling events are constitutively engaged.

Conclusions:

  • LMP1's function as a constitutively active receptor drives its oncogenic potential.
  • The molecular interactions initiated by LMP1 explain its role in EBV-driven cell transformation.

Related Experiment Videos